Results 301 to 310 of about 183,816 (344)
Some of the next articles are maybe not open access.
Clinical Pharmacokinetics of Ciprofloxacin
Clinical Pharmacokinetics, 1990Compared with nalidixic acid, ciprofloxacin is representative of a newer, more potent class of quinolones, termed the fluoroquinolones. It is available in both oral and parenteral dosage forms. The primary target of quinolone activity appears to be the bacterial DNA gyrase enzyme, which is a member of the class of type II topoisomerases.
John C. Rotschafer +2 more
openaire +2 more sources
Ciprofloxacin in combination with metronidazole
Infection, 1988Ciprofloxacin has a reduced activity against anaerobic pathogens. Therefore, a combination of ciprofloxacin with an antimicrobial agent active against anaerobes, such as metronidazole, seems to be interesting for the treatment of mixed aerobic/anaerobic infections. High metronidazole concentrations (10 mg/l or 40 mg/l) neither affected the bactericidal
R. Werk, L. Schneider
openaire +3 more sources
Annals of Internal Medicine, 1989
Excerpt The recent letter by Linville and Matanin (1) brought attention to an interaction between norfloxacin (Noroxin, Merck Sharp & Dohme, West Point, Pennsylvania) and warfarin that resulted in ...
Sean M. Murphy +2 more
openaire +2 more sources
Excerpt The recent letter by Linville and Matanin (1) brought attention to an interaction between norfloxacin (Noroxin, Merck Sharp & Dohme, West Point, Pennsylvania) and warfarin that resulted in ...
Sean M. Murphy +2 more
openaire +2 more sources
Adsorption of ciprofloxacin from water: A comprehensive review
, 2021C. Igwegbe +5 more
semanticscholar +1 more source
Metabolic interactions of ciprofloxacin
Diagnostic Microbiology and Infectious Disease, 1990The mechanism and clinical relevance of the inhibitory effect of ciprofloxacin on the metabolism of selected drugs were studied in patients with bacterial infections. In study A, antipyrine tests were carried out in two groups of patients taking 1000 mg (group 1) and 250 mg (group 2) of oral ciprofloxacin for 7-10 days.
András Csiba +3 more
openaire +2 more sources
Ciprofloxacin for treatment of malakoplakia
The Lancet, 1992The tumour-like lesions of the rare disease malakoplakia, which consist of macrophages containing undigested coliform bacteria, are often misdiagnosed as a carcinoma. Although an infectious aetiology is likely, no antimicrobial therapy has been successful in the long-term. Since ciprofloxacin penetrates well into macrophages, this drug was given to two
P.A. Wertheimer +3 more
openaire +2 more sources
, 2016
A new imprinted photocatalyst ICTX@Mfa is prepared by employing a molecular imprinting technique, which is authenticated via a variety of modern analysis methods. It exhibits superior specific oriented recognition capability, stability and retrievability
Ziyang Lu +9 more
semanticscholar +1 more source
A new imprinted photocatalyst ICTX@Mfa is prepared by employing a molecular imprinting technique, which is authenticated via a variety of modern analysis methods. It exhibits superior specific oriented recognition capability, stability and retrievability
Ziyang Lu +9 more
semanticscholar +1 more source
, 2016
We have developed a novel and efficient electrochemical sensor to measure ciprofloxacin using a composite of magnetic multi-walled carbon nanotubes (MMWCNTs) and molecularly imprinted polymer (MIP).
H. Bagheri +3 more
semanticscholar +1 more source
We have developed a novel and efficient electrochemical sensor to measure ciprofloxacin using a composite of magnetic multi-walled carbon nanotubes (MMWCNTs) and molecularly imprinted polymer (MIP).
H. Bagheri +3 more
semanticscholar +1 more source